Series C funding round for Syndax Pharmaceuticals raising $80M in August 2015
Series C funding round for Syndax Pharmaceuticals raising $80M in August 2015
| Investor | Firm Type | Partner |
|---|
FidelityLEAD | Venture Capital | — |
DelosLEAD | Private | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$167M
Top Valuation
-
Syndax Pharmaceuticals raised $80M in a Series C round.
The round was announced on 08/01/15.
The round was led by Delos, Fidelity Management & Research Company.